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VoicesCell Metabolism 10th AnniversaryIn celebration of Cell Metabolism’s 10th anniversary, we asked the founding editors of Cell
Metabolism, as well as the past and current CEOs of Cell Press, for their reflections.The Birth of Cell Metabolismelman
cer Institute
Lynne Herndon
President and CEO, Cell Press, 2001–2011
Jeffrey Flier
Harvard Medical SchoolThe idea for what eventually became
Cell Metabolism originated at a dinner
with Jeff Flier and Jeff Friedman, during
which we discussed two independent
questions. First, was the field of molec-
ular metabolism in need of a journal
that it could call ‘‘home’’? Second,
could a man order one (or many)
pink cocktails and maintain some
semblance of masculinity? After this
dinner we approached the five other
founding editors and asked if they
wanted to join in this quest.
The ‘‘group of eight’’ then approached
four journals, Cell, Nature, Science,
andGenes andDevelopment (see sam-
ple letter, pp. 6), and asked if they
would be interested in exploring
the founding of a new journal devoted
to publishing high-quality work in
the field of molecular metabolism.
While Nature, Science and Genes and
Development showed little interest,
Cell responded with great enthusiasm.
In fact, Emilie Marcus (Editor-in-Chief
at Cell) and Lynne Herndon (then-Pres-
ident of Cell Press) invited us to their
offices in Cambridge to explore these
ideas. We were pleased to find that
Emilie and Lynn were not only inter-
ested, but they had put together
some of their own ideas regarding the
structure and subject matter to be
covered by this new journal! Their
partnership in building Cell Metabolism
was invaluable and helped shape the
journal as it exists today.A Happy MarriageAs a publisher, I know how exciting
it is to launch a new journal. Cell
Metabolism got its start ten years ago
in a rather unusual way. I remember
receiving a letter on Rockefeller statio-
nery from the group of scientists who
are now the founding editors for the
journal. In that letter, they asserted
that metabolism had become far more
than basic physiology and that the
time was right for a new journal. And
their preference was that it be a Cell
Press journal. We met, we debated,
we checked their assertions, and we
ultimately agreed that the time was
right. With quick but exacting action,
the scientific publishing partnership
called Cell Metabolism was born. And
so history was made, and it has been
exciting all the way. In a celebratory
dinner in October 2004, a few months
after we launched, Cell Press toasted
the founding editors for their vision
and commitment, and they toasted us
for our execution and the impact we
had achieved. I have warm memories
of interactions with four of the North-
east-based founding editors who
joined us at that table: Jeffrey Flier,
Jeff Friedman, Ron Kahn, and Bruce
Spiegelman. Thanks to them for their
enthusiastic support. Congratulations,
Cell Press!Cell MetabolismCellMetabolism, ThenandNow.Cell Metabolismwas founded ten years
ago after Bruce Spiegelman, Jeff Fried-
man, and I proposed the idea to Cell
Press, seeking a newhigh-quality outlet
formetabolic research. This experiment
was quickly pronounced a success by
the field, and I am very proud of this
outcome. Since its founding, my career
has evolved from a physician-scientist
pursuing questions at the heart of
metabolism—how does the brain con-
trol appetite and metabolism, what is
the physiology of leptin and how is it
altered in obesity, are brain energy bal-
ance circuits plastic, are there undis-
covered mediators of all this—to being
the dean of a pretty amazing school.
That transition required me to focus
on the key unanswered questions in
biomedical research and education
more broadly. In this role, creativity,
ambition, and drive remain essential
requirements, but now in service of a
broader, but surely no less important,
mission. My deep-seated passion for
puzzle-solving in metabolism, a key
topic for human health, continues
through collaboration with my wife,
Terry Maratos-Flier, and this brings
significant pleasure, aswell aswelcome
relief from administrative burdens. And
I note that while I’ve been focusing
elsewhere, the major questions that
puzzled me most in the field remain
largely unanswered. So I plan to keep
reading, and perhaps even publishing,
in Cell Metabolism.21, January 6, 2015 ª2015 Elsevier Inc. 3
Cell Metabolism
VoicesCell Metabolism and the
Evolution of the FieldStephen O’Rahilly
Cambridge University
C. Ronald Kahn
Joslin Diabetes Center
Jeffrey Friedman
Rockefeller UniversityAs we celebrate the 10th anniversary of
Cell Metabolism, we can appreciate
how much progress the field has en-
joyed over the past decade, and how
much the journal has helped not only
to disseminate this information, but to
stimulate research in the field. Under-
standing regulation of metabolism and
its alterations in diseases has classi-
cally been the domain of the endocri-
nologist. However, this is no longer
true. Indeed, the fields of cell meta-
bolism and its regulation by hormones
and other mediators are undergoing a
modern evolution before our very
eyes. New peptide and nonpeptide
mediators of inter- and intracellular
communication are being discovered
every year. At the same time, known
hormones are having previously un-
known effects, often in tissues that
would never have been considered
part of their natural spectrum of tar-
gets: insulin action in brain, osteocalcin
effects on glucose metabolism, and
bone growth factors stimulating brown
fat and energy metabolism. The ques-
tion is: what will the next ten years
reveal? I predict many more exciting
new findings further expanding the
role of inter- and intracellular communi-
cation and the role of Cell Metabolism
in disseminating this information. Even
after four decades working in this field,
I find the opportunity for new discovery
more exciting than ever. I am looking
forward to the 20th anniversary of the
journal and all the new science it will
bring.4 Cell Metabolism 21, January 6, 2015 ª2015Public Discourse on Metabolic
DiseaseAs articulated in a letter from its found-
ing editors in the inaugural journal, Cell
Metabolism was started with several
goals, the first being to ‘‘give voice to
[scientists’] efforts to understand the
molecular basis of metabolic disease’’
(Brown et al., 2005; Cell Metabolism
1, 3). In my view, Cell Metabolism
has met this high bar and also helped
to create a more cohesive field by
providing a framework for promoting
interactions. A second goal discussed
in the letter was to help ‘‘frame public
discussion’’ of metabolic disease.
This objective was high on my list,
borne of the frustration that discussion
of the public health implications of
metabolic disease does not adequately
reflect the view of basic scientists.
Rather, in public discourse the focus
remains on the ‘‘explosion’’ of obesity
in the developed world, often leading
to the proposed remedy that obese
people should eat less and exercise
more, a recommendation first made
by Hippocrates. Simplifying the prob-
lem in this way has damaging conse-
quences, including chilling investment
in basic research that will ultimately
provide answers to our health prob-
lems. It also promulgates the
misguided notion that the obese are
to blame for their condition. Perhaps
now that Cell Metabolism is estab-
lished as a premier scientific journal,
this scientific community together
with Cell Metabolism can find ways
to provide thought leaders with an
opportunity to communicate their
views with the public more effectively,
including publishing ‘‘white’’ papers
on these topics.Elsevier Inc.A View from the Old WorldCell Metabolism has had a blooming
infancy and childhood, and like all
anxious parents, I hope for a trouble-
free transition to adulthood. To nego-
tiate the bumpy adolescent period, I
would like the journal to ponder two
issues. First, while human studies
sometimes appear in the journal, they
do so rarely. Cell Metabolism does
not strike clinical investigators as a
natural home for their best papers.
The growing power of human genetics
and phenotyping means that strong
mechanistic studies can now be under-
taken in humans. My second concern
pertains to the irreproducibility of an
appreciable fraction of the scientific
literature. I fear that we (researchers
and institutions, funding bodies and
journals) have created a toxic mix of in-
centives whereby scientific success is
measured not by the production of a
carefully conducted and soberly re-
ported body of work of lasting signifi-
cance, but by the frequency of news-
worthy papers published in high-
profile journals. This encourages scien-
tists and editors to produce polished
and apparently complete ‘‘stories,’’ a
substantial fraction of which fail to
stand the test of time. Addressing this
issue will be complex but is essential
if academic science is to continue to
be supported by taxpayers, charities,
and industry.
Cell Metabolism
VoicesPublicize or PerishEmilie Marcus
CEO, Cell Press
Michael S. Brown and Joseph L. Goldstein
University of Texas Southwestern Medical CenterWhen a scientist makes a discovery,
what should the public know and
when should they know it? Discoveries
that appear exciting often turn out to be
mistakes or artifacts. When presented
in mass media as breakthroughs, they
create false hope, particularly for
devastating diseases like childhood
diabetes or cancer. The recent spate
of false claims results from confluent
pressures on scientists, institutions,
and media, all craving the limelight.
For scientists, publicity brings fame,
promotions, and salary increases. For
universities, laudatory articles bring
funds, patients, and kudos for their
press offices. For the media, sensa-
tional claims attract readers. When an
exaggerated claim is later found false,
the media has no incentive to report
the error. Universities and scientists
also avoid public admission unless
fraud is alleged. The public is confused.
What is the answer? First, we must
teach people the central tenet of sci-
ence: facts are accepted provisionally
until they survive repeated attempts at
falsification. Second, we should hold
scientists and universities accountable
for publicizing erroneous claims. Sci-
entists are entitled to interpret their
data freely in a scientific paper where
knowledgeable readers can judge
validity. The public lacks the basis to
evaluate scientific claims. When Kohler
and Milstein invented monoclonal
antibodies—the greatest therapeutic
advance in recent times—they sought
no publicity, even though their 1975
Nature paper acknowledged the
medical implications. Their restraint is
a lesson to us all.CowabungaWhen it comes to launching new jour-
nals, as a publisher your eyes are
always keenly focused on the horizon.
Like surfers deciding which wave to
ride, you have to get it right, and that
takes a unique combination of data,
vision, and intuition. Paddle out too
soon and catch a wave that fades
before it reaches the shore and you
have wasted your time and effort;
paddle out too late for a wave that
breaks before you get to it and it churns
you over as it rushes past you to land.
When the fateful letter arrived on
Lynne Herndon’s desk over ten years
ago suggesting the creation of a new
journal focused on metabolism and
homeostasis, the proposal had all the
trappings of the perfect wave. Cell
Press was poised on expanding our
scope to bridge basic and translational
science with new journals in clinically
oriented areas. The letter was penned
by a number of distinguished leaders
in the field; it was thoughtful, well-
reasoned, and strategic. And when
we analyzed the trajectory of research
output in the field, it was clear that
article numbers and quality were
beginning to grow nonlinearly. So
thank you to the founding editors for
standing on the shore with us and
pointing out such a great ride; we are
happy to have been there as a partner
from the early days of exciting research
in modern metabolism. And thank you
to all the authors, reviewers, readers,
and editorial board members who
have made the journal such a success.
Ten years in and Cell Met is definitely
in the tube. So—pun fully intended—
hang ten, Cell Met!Cell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc. 5
